HANSBIOMED CORPORATION HansBiomed Corporation Stock
Equities
A042520
KR7042520007
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,890 KRW | +0.62% |
|
-1.90% | -12.19% |
| 02-14 | HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
| 2023 | HansBiomed Corporation(KOSDAQ:A042520) added to S&P Global BMI Index | CI |
| Sales 2022 | 74.46B 54.06M 73.79M | Sales 2023 | 78.03B 56.65M 77.33M | Capitalization | 208B 151M 206M |
|---|---|---|---|---|---|
| Net income 2022 | 6.15B 4.46M 6.09M | Net income 2023 | -23.04B -16.73M -22.84M | EV / Sales 2022 | 1.82 x |
| Net Debt 2022 | 42.36B 30.75M 41.97M | Net Debt 2023 | 34.09B 24.75M 33.79M | EV / Sales 2023 | 3.1 x |
| P/E ratio 2022 |
53.3
x | P/E ratio 2023 |
-8.34
x | Employees | 254 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 60.39% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.62% | ||
| 1 week | -1.90% | ||
| Current month | -5.77% | ||
| 1 month | -7.93% | ||
| 3 months | +11.22% | ||
| 6 months | -12.25% | ||
| Current year | -12.19% |
1 week
12 750.00
13 550.00
1 month
12 750.0014 970.00
Current year
11 050.0016 600.00
1 year
11 050.0029 700.00
3 years
9 010.0029 700.00
5 years
9 010.0029 700.00
10 years
9 010.0034 750.00
| Managers | Title | Age | Since |
|---|---|---|---|
Geun-Young Kim
CEO | Chief Executive Officer | 60 | - |
Ho-Chan Hwang
BRD | Director/Board Member | 65 | - |
Chang-Hee Kim
AUD | Comptroller/Controller/Auditor | 58 | 17-12-05 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ho-Chan Hwang
BRD | Director/Board Member | 65 | - |
Geun-Young Kim
CEO | Chief Executive Officer | 60 | - |
Sang-Seok Oh
BRD | Director/Board Member | 54 | 19-12-25 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 12,890 | +0.62% | 22,355 |
| 24-04-25 | 12,810 | -3.17% | 44,632 |
| 24-04-24 | 13,230 | 0.00% | 18,907 |
| 24-04-23 | 13,230 | +0.08% | 17,428 |
| 24-04-22 | 13,220 | +0.61% | 47,265 |
End-of-day quote Korea S.E., April 25, 2024
More quotes
HansBiomed Co.,Ltd is a Korea-based company engaged in the biotechnology industry. The Company mainly provides three categories of products: skin-implant materials, bone-implant materials and silicone products. Its skin-implant materials are used for burn treatment and skin graft under the brand names of SureDerm, BellaGen and GPS. Its bone-implant materials include allogeneic bones, xenogenous bones and synthetic bones used in dentistry, orthopedic and others, which are under the brand names of SureFuse, ExFuse and SureOss. Its silicone products are used for treatments of scars and for breast implant and others, which are under the brand names of BellaGel and Scar Clinic. In addition, it provides hair transplanters and others.
Calendar
2024-05-12
- Q2 2024 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.19% | 122M | |
| +12.07% | 128B | |
| -8.43% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B |
- Stock Market
- Equities
- A042520 Stock
